5301 - 5325 of 9145 Results
Title
Year
- Substantia nigra hyperechogenicity is related to decline in verbal memory in healthy elderly adults2016RESTRICTEDTitle: Substantia nigra hyperechogenicity is related to decline in verbal memory in healthy elderly adultsJournal Name: European Journal of NeurologyPublisher: WileyVol: 23Issue #: 5Start Page: 973End Page: 978Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ene.12974Citation Count: 15
- Pharmacological Inhibition of PTEN Rescues Dopaminergic Neurons by Attenuating Apoptotic and Neuroinflammatory Signaling Events2023RESTRICTEDTitle: Pharmacological Inhibition of PTEN Rescues Dopaminergic Neurons by Attenuating Apoptotic and Neuroinflammatory Signaling EventsJournal Name: Journal of Neuroimmune PharmacologyPublisher: Springer Science and Business Media LLCVol: 18Issue #: 3Start Page: 462End Page: 475Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11481-023-10077-8Citation Count: 6
-
OPENTitle: Mutant Allele-Specific CRISPR Disruption in DYT1 Dystonia Fibroblasts Restores Cell FunctionJournal Name: Molecular Therapy Nucleic AcidsPublisher: Elsevier BVVol: 21Issue #:Start Page: 1End Page: 12Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.omtn.2020.05.009Best OA location URL: http://www.cell.com/article/S2162253120301359/pdfCitation Count: 13
- Automated Deep Brain Stimulation Programming for Tremor2018RESTRICTEDTitle: Automated Deep Brain Stimulation Programming for TremorJournal Name: IEEE Transactions on Neural Systems and Rehabilitation EngineeringPublisher: Institute of Electrical and Electronics Engineers (IEEE)Vol: 26Issue #: 8Start Page: 1618End Page: 1625Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1109/tnsre.2018.2852222Citation Count: 40
-
OPENTitle: ADNC-RS, a clinical-genetic risk score, predicts Alzheimer’s pathology in autopsy-confirmed Parkinson’s disease and Dementia with Lewy bodiesJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 140Issue #: 4Start Page: 449End Page: 461Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00401-020-02199-7Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7864557Citation Count: 15
-
OPENTitle: Parkinson's disease pathology is directly correlated to SIRT3 in human subjects and animal models: Implications for AAV.SIRT3-myc as a disease-modifying therapyJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 187Issue #:Start Page: 106287End Page: 106287Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2023.106287Best OA location URL: https://doi.org/10.1016/j.nbd.2023.106287Citation Count: 11
- Vitamin B12 and Homocysteine Levels Predict Different Outcomes in Early Parkinson's Disease2018RESTRICTEDTitle: Vitamin B12 and Homocysteine Levels Predict Different Outcomes in Early Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 5Start Page: 762End Page: 770Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27301Citation Count: 94
-
OPENTitle: Preparation of S-glycoside surfactants and cysteine thioglycosides using minimally competent Lewis acid catalysisJournal Name: Carbohydrate ResearchPublisher: Elsevier BVVol: 422Issue #:Start Page: 1End Page: 4Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.carres.2015.12.008Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8876251Citation Count: 19
- Highly sensitive HPLC-MS/MS assay for the quantitation of ondansetron in rat plasma and rat brain tissue homogenate following administration of a very low subcutaneous dose2019RESTRICTEDTitle: Highly sensitive HPLC-MS/MS assay for the quantitation of ondansetron in rat plasma and rat brain tissue homogenate following administration of a very low subcutaneous doseJournal Name: Journal of Pharmaceutical and Biomedical AnalysisPublisher: Elsevier BVVol: 175Issue #:Start Page: 112766End Page: 112766Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jpba.2019.07.014Citation Count: 11
-
OPENTitle: Epigenetic ageing and the risk of Parkinson’s diseaseJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 97Issue #: 5Start Page: 385End Page: 392Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1136/jnnp-2025-336802Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC12915515/Citation Count: 0
- Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortium2011OPENTitle: Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortiumJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 307Issue #: 1-2Start Page: 22End Page: 29Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2011.05.031Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3155471Citation Count: 60
- Reversible orolingual dyskinesia in a case of juvenile onset psychosis and cognitive decline: Expert commentary2020RESTRICTEDTitle: Reversible orolingual dyskinesia in a case of juvenile onset psychosis and cognitive decline: Expert commentaryJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 76Issue #:Start Page: 78End Page: 79Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.12.015Citation Count: 1
-
OPENTitle: Unraveling the intersection of aging and Parkinson’s disease: a collaborative roadmap for advancing research modelsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page: 28End Page: 28Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-01239-xBest OA location URL: https://www.nature.com/articles/s41531-025-01239-x_reference.pdfCitation Count: 1
- Co-registration of Imaging Modalities (MRI, CT and PET) to Perform Frameless Stereotaxic Robotic Injections in the Common Marmoset2021RESTRICTEDTitle: Co-registration of Imaging Modalities (MRI, CT and PET) to Perform Frameless Stereotaxic Robotic Injections in the Common MarmosetJournal Name: NeurosciencePublisher: Elsevier BVVol: 480Issue #:Start Page: 143End Page: 154Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2021.11.009Citation Count: 13
- Engineering Iron Responses in Mammalian Cells by Signal-Induced Protein Proximity2017RESTRICTEDTitle: Engineering Iron Responses in Mammalian Cells by Signal-Induced Protein ProximityJournal Name: ACS Synthetic BiologyPublisher: American Chemical Society (ACS)Vol: 6Issue #: 6Start Page: 921End Page: 927Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acssynbio.6b00255Citation Count: 17
-
OPENTitle: Single‐Molecule Counting Coupled to Rapid Amplification Enables Detection of α‐Synuclein Aggregates in Cerebrospinal Fluid of Parkinson's Disease PatientsJournal Name: Angewandte ChemiePublisher: WileyVol: 133Issue #: 21Start Page: 11981End Page: 11990Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/ange.202014898Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ange.202014898Citation Count: 24
-
OPENTitle: Mapping typical and hypokinetic dysarthric speech production network using a connected speech paradigm in functional MRIJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 27Issue #:Start Page: 102285End Page: 102285Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2020.102285Best OA location URL: https://doi.org/10.1016/j.nicl.2020.102285Citation Count: 10
-
OPENTitle: Healthcare access and utilization of deep brain stimulation and supplementary care in black and white patients with Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 140Issue #:Start Page: 108057End Page: 108057Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.108057Best OA location URL: https://doi.org/10.1016/j.parkreldis.2025.108057Citation Count: 0
- Effect of dopaminergic medications on Montreal Cognitive Assessment in Parkinson's disease patients2025RESTRICTEDTitle: Effect of dopaminergic medications on Montreal Cognitive Assessment in Parkinson's disease patientsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 138Issue #:Start Page: 107951End Page: 107951Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107951Citation Count: 0
-
OPENTitle: Synthesis and characterization of a series of chiral alkoxymethyl morpholine analogs as dopamine receptor 4 (D4R) antagonistsJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 26Issue #: 10Start Page: 2481End Page: 2488Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2016.03.102Best OA location URL: http://doi.org/10.1016/j.bmcl.2016.03.102Citation Count: 26
-
OPENTitle: Acute Levodopa Challenge Test in Patients with de novo Parkinson's Disease: Data from the DeNoPa CohortJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 4Issue #: 5Start Page: 755End Page: 762Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12511Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12511Citation Count: 44
-
OPENTitle: Increased Serum Neurofilament Light Chain Levels in Parkinson's Disease Patients Carrying the p. A53T SNCA Mutation: Data from the Parkinson's Progression Markers Initiative StudyJournal Name: Movement DisordersPublisher: WileyVol: 41Issue #: 6Start Page: 1580End Page: 1585Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.70236Best OA location URL: https://doi.org/10.1002/mds.70236Citation Count: 0
-
OPENTitle: Ade novocompound targeting α-synuclein improves deficits in models of Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 139Issue #: 12Start Page: 3217End Page: 3236Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/aww238Best OA location URL: https://academic.oup.com/brain/article-pdf/139/12/3217/24173157/aww238.pdfCitation Count: 156
-
RESTRICTEDTitle: Effects of aging on the ventral and dorsal substantia nigra using diffusion tensor imagingJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 33Issue #: 1Start Page: 35End Page: 42Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2010.02.006Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/2908724Citation Count: 55
- Promise and Challenge of β-Lactone Electrophiles to Target Aspartate 12 of Mutant KRASG12D2025RESTRICTEDTitle: Promise and Challenge of β-Lactone Electrophiles to Target Aspartate 12 of Mutant KRASG12DJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 68Issue #: 14Start Page: 15050End Page: 15064Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.jmedchem.5c01214Citation Count: 3